59 related articles for article (PubMed ID: 1357834)
1. The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy.
Koh EH; Chung HC; Lee KB; Lim HY; Kim JH; Roh JK; Min JS; Lee KS; Kim BS
Yonsei Med J; 1992 Jun; 33(2):137-42. PubMed ID: 1357834
[TBL] [Abstract][Full Text] [Related]
2. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of P-glycoprotein expression in breast cancer: clinical correlations.
Decker DA; Morris LW; Levine AJ; Pettinga JE; Grudzien JL; Farkas DH
Ann Clin Lab Sci; 1995; 25(1):52-9. PubMed ID: 7762969
[TBL] [Abstract][Full Text] [Related]
4. Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.
Chintamani ; Singhal V; Singh JP; Lyall A; Saxena S; Bansal A
BMC Cancer; 2004 Aug; 4():48. PubMed ID: 15310398
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Ro J; Sahin A; Ro JY; Fritsche H; Hortobagyi G; Blick M
Hum Pathol; 1990 Aug; 21(8):787-91. PubMed ID: 1974874
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma.
Verrelle P; Meissonnier F; Fonck Y; Feillel V; Dionet C; Kwiatkowski F; Plagne R; Chassagne J
J Natl Cancer Inst; 1991 Jan; 83(2):111-6. PubMed ID: 1671103
[TBL] [Abstract][Full Text] [Related]
7. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.
Salmon SE; Grogan TM; Miller T; Scheper R; Dalton WS
J Natl Cancer Inst; 1989 May; 81(9):696-701. PubMed ID: 2565403
[TBL] [Abstract][Full Text] [Related]
8. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
9. Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients.
Schneider J; Romero H
Anticancer Res; 1995; 15(3):1117-21. PubMed ID: 7645934
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
Dixon AR; Bell J; Ellis IO; Elston CW; Blamey RW
Br J Cancer; 1992 Sep; 66(3):537-41. PubMed ID: 1355661
[TBL] [Abstract][Full Text] [Related]
12. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
[TBL] [Abstract][Full Text] [Related]
13. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
[TBL] [Abstract][Full Text] [Related]
14. Pathological assessment of response to induction chemotherapy in breast cancer.
Feldman LD; Hortobagyi GN; Buzdar AU; Ames FC; Blumenschein GR
Cancer Res; 1986 May; 46(5):2578-81. PubMed ID: 3697997
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer.
Chung HC; Gong SJ; Yoo NC; Noh SH; Kim JH; Roh JK; Min JS; Kim BS; Lee KB
Yonsei Med J; 1996 Dec; 37(6):397-404. PubMed ID: 9048492
[TBL] [Abstract][Full Text] [Related]
17. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
19. Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients.
Parissenti AM; Chapman JA; Kahn HJ; Guo B; Han L; O'Brien P; Clemons MP; Jong R; Dent R; Fitzgerald B; Pritchard KI; Shepherd LE; Trudeau ME
Breast Cancer Res Treat; 2010 Jan; 119(2):347-56. PubMed ID: 19771508
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
